Department of Internal Medicine Grand Rounds
Jennifer McCracken, MD
Division of Allergy
Department of Internal Medicine
Thursday, September 19, 2019
12:00pm - 1:00pm
Clinical Science Auditorium, 3.362
Objectives: At this conclusion of this presentation, participants should be able to:
- Review conventional therapies for moderate to severe persistent asthma
- Discuss FDA approved biologic treatments for moderate to severe persistent asthma
- Describe potential new targets for future biologic therapies
Disclosure Statement (Speaker): Dr. Jennifer McCracken has no relevant financial relationship with commercial interests to disclose.
Educational Method: Lecture
Target Audience: MDs, Residents, Students and Alumni
Disclosure Statement (Planning Committee Members): Dr. Rex McCallum, Dr. Lindsay Sonstein, Dr. Bernard Karnath, and Brenda Johnson MEd, CHCP have no relevant financial relationships with commercial interests to disclose.
CME Statements: The University of Texas Medical Branch at Galveston is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas Medical Branch at Galveston designates this live activity for a maximum of 52 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Everyone is welcome.